Literature DB >> 23945146

Correction: Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.

Miceala Martinez1, Nadia Ono, Marina Planutiene, Kestutis Planutis, Edward L Nelson, Randall F Holcombe.   

Abstract

Entities:  

Year:  2013        PMID: 23945146      PMCID: PMC3751084          DOI: 10.1186/1475-2867-13-80

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


× No keyword cloud information.

Correction

After publication of the original article [1] it came to the publishers attention that the article was incorrectly published as an Editorial instead of the correct article type; Primary Research. We apologise for any inconvenience this has caused.
  1 in total

1.  Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.

Authors:  Micaela Martinez; Nadia Ono; Marina Planutiene; Kestutis Planutis; Edward L Nelson; Randall F Holcombe
Journal:  Cancer Cell Int       Date:  2012-01-23       Impact factor: 5.722

  1 in total
  1 in total

1.  Downregulation of Runx3 is closely related to the decreased Th1-associated factors in patients with gastric carcinoma.

Authors:  Yazhen Li; Xiaoyun Ji; Zhaoliang Su; Jia Tong; Sheng Xia; Xiaobo Chen; Ping Lu; Prince Amoah Barnie; Shengjun Wang; Xinxiang Huang; Huaxi Xu
Journal:  Tumour Biol       Date:  2014-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.